These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32788885)
1. Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies. Javanmard SH; Vaseghi G; Ghasemi A; Rafiee L; Ferns GA; Esfahani HN; Nedaeinia R Cancer Cell Int; 2020; 20():384. PubMed ID: 32788885 [TBL] [Abstract][Full Text] [Related]
2. Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach. Nedaeinia R; Sharifi M; Avan A; Kazemi M; Rafiee L; Ghayour-Mobarhan M; Salehi R Cancer Gene Ther; 2016 Aug; 23(8):246-53. PubMed ID: 27364574 [TBL] [Abstract][Full Text] [Related]
3. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma. Najafi Z; Sharifi M; Javadi G J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia. Dehkordi KA; Chaleshtori MH; Sharifi M; Jalili A; Fathi F; Roshani D; Nikkhoo B; Hakhamaneshi MS; Sani MRM; Ganji-Arjenaki M Indian J Hematol Blood Transfus; 2017 Sep; 33(3):327-332. PubMed ID: 28824233 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma. Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979 [TBL] [Abstract][Full Text] [Related]
6. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Sharifi M; Salehi R Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. Di Martino MT; Gullà A; Gallo Cantafio ME; Altomare E; Amodio N; Leone E; Morelli E; Lio SG; Caracciolo D; Rossi M; Frandsen NM; Tagliaferri P; Tassone P PLoS One; 2014; 9(2):e89659. PubMed ID: 24586944 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer. Torres A; Kozak J; Korolczuk A; Wdowiak P; Domańska-Glonek E; Maciejewski R; Torres K BMC Cancer; 2016 Oct; 16(1):822. PubMed ID: 27782822 [TBL] [Abstract][Full Text] [Related]
9. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells. Vandghanooni S; Eskandani M; Barar J; Omidi Y Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975 [TBL] [Abstract][Full Text] [Related]
10. miR-20a inhibition using locked nucleic acid (LNA) technology and its effects on apoptosis of human macrophages infected by Toxoplasma gondii RH strain. Rezaei F; Daryani A; Sharifi M; Sarvi S; Jafari N; Pagheh AS; Hashemi N; Hejazi SH Microb Pathog; 2018 Aug; 121():269-276. PubMed ID: 29800695 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
12. Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo. Torres A; Kozak J; Korolczuk A; Rycak D; Wdowiak P; Maciejewski R; Torres K Oncotarget; 2016 Nov; 7(45):73651-73663. PubMed ID: 27655663 [TBL] [Abstract][Full Text] [Related]
13. miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling. Santolla MF; Lappano R; Cirillo F; Rigiracciolo DC; Sebastiani A; Abonante S; Tassone P; Tagliaferri P; Di Martino MT; Maggiolini M; Vivacqua A J Exp Clin Cancer Res; 2018 May; 37(1):94. PubMed ID: 29716623 [TBL] [Abstract][Full Text] [Related]
14. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration. Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Hinkel R; Penzkofer D; Zühlke S; Fischer A; Husada W; Xu QF; Baloch E; van Rooij E; Zeiher AM; Kupatt C; Dimmeler S Circulation; 2013 Sep; 128(10):1066-75. PubMed ID: 23897866 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1. Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia. Sharifi M; Salehi R; Gheisari Y; Kazemi M Adv Biomed Res; 2014; 3():61. PubMed ID: 24627869 [TBL] [Abstract][Full Text] [Related]
18. Anticancer effects of miR-200c in colorectal cancer through BMI1. Karimi Mazraehshah M; Tavangar SM; Saidijam M; Amini R; Bahreini F; Karimi Dermani F; Najafi R J Cell Biochem; 2018 Dec; 119(12):10005-10012. PubMed ID: 30171714 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction in acute promyelocytic leukemia cells through upregulation of Sharifi M; Fasihi-Ramandi M; Sheikhi A; Moridnia A; Saneipour M Mol Biol Res Commun; 2018 Mar; 7(1):25-33. PubMed ID: 29911120 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4. Nedaeinia R; Sharifi M; Avan A; Kazemi M; Nabinejad A; Ferns GA; Ghayour-Mobarhan M; Salehi R Tumour Biol; 2017 Mar; 39(3):1010428317692261. PubMed ID: 28347230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]